Yardeni D, Ghany MG. Review article: hepatitis B-current and emerging therapies. Aliment Pharmacol Ther. 2022;55(7):805–19.
Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ. 2011;163:407–19.
Tomé-Bermejo F, Piñera AR, Alvarez L. Osteoporosis and the management of spinal degenerative disease (II). Arch Bone Jt Surg. 2017;5(6):363–74.
Cummings JL, Tong G, Ballard C. Treatment combinations for alzheimer’s disease: current and future pharmacotherapy options. J Alzheimer’s Dis. 2019;67(3):779–94.
Yiannopoulou KG, Papageorgiou SG. Current and future treatments in alzheimer disease: An update. J Cent Nerv Syst Dis. 2020;12:117957352090739.
Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimer’s Dement Transl Res Clin Interv. 2018;2018(4):195–214.
Ding M, Tegel H, Sivertsson Å, Hober S, Snijder A, Ormö M, et al. Secretome-based screening in target discovery. SLAS Discov. 2020;25(6):535–51.
Rahmadewi R, Retha R, Pitasari DA, Kusumastanto VA, Ardhaninggar AAA, Citrashanty I, et al. The efficacy of amniotic membrane stem cell (AMSC) metabolite product and vitamin E for wrinkles, spots, and pores in photoaging. Dermatol Res Pract. 2020;2020:1–5.
Kropp C, Massai D, Zweigerdt R. Progress and challenges in large-scale expansion of human pluripotent stem cells. Process Biochem. 2017;59:244–54.
Herberts CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9(1):29.
Plotnikov EY, Silachev DN, Popkov VA, Zorova LD, Pevzner IB, Zorov SD, et al. Intercellular signalling cross-talk: to kill, to heal and to rejuvenate. Hear Lung Circ. 2017;26(7):648–59.
Rikhtegar R, Pezeshkian M, Dolati S, Safaie N, Afrasiabi Rad A, Mahdipour M, et al. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts. Biomed Pharmacother. 2018;2019(109):304–13.
Tamama K, Kerpedjieva SS. Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells. Adv Wound Care. 2012;1(4):177–82.
Huddleston HP, Cohn MR, Haunschild ED, Wong SE, Farr J, Yanke AB. Amniotic product treatments: Clinical and basic science evidence. Curr Rev Musculoskelet Med. 2020;13(2):148–54.
Prakoeswa CRS, Pratiwi FD, Herwanto N, Citrashanty I, Indramaya DM, Murtiastutik D, et al. The effects of amniotic membrane stem cell-conditioned medium on photoaging. J Dermatolog Treat. 2019;30(5):478–82.
Damayanti RH, Rusdiana T, Wathoni N. Mesenchymal stem cell secretome for dermatology application: A review. Clin Cosmet Investig Dermatol. 2021;14:1401–12.
Teixeira FG, Serra SC, Salgado AJ. Tips on how to collect and administer the mesenchymal stem cell secretome for central nervous system applications. Methods Mol Biol. 2016;1416:457–65.
Bennett NT, Schultz GS. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg. 1993;165(6):728–37.
Sari DIK, Erawati T, Miatmoko A, Prakoeswa CRS, Soeratri W. Characterization and stability study of amniotic membrane stem cell metabolite product (AMSC-MP). Int J Pharma Res Heal Sci. 2020;8(1):3126–30.
Chen G, Gulbranson DR, Yu P, Hou Z, Thomson JA. Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells. 2012;30(4):623–30.
Tan JCG, Webb RG, Marks DC. Serum growth factor stability in different eye drop packaging systems during storage. Transfus Apher Sci. 2020;59(1):102608.
Mizumachi H, Ijima H. Measuring stability of vascular endothelial growth factor using an immobilization technique. Adv Biomed Eng. 2013;2:130–6.
Chen BLU, Arakawa T. Stabilization of recombinant human keratinocyte growth factor by osmolytes and salts. J Pharm Sci. 1996;85(4):419–22.
Zhang HY, Wang ZG, Wu FZ, Kong XX, Yang J, Lin BB, et al. Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury. Mol Neurobiol. 2013;48(3):452–64.
Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy Andrew. Nat Rev Drug Discov. 2009;8(3):1–7.
Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams Textbook of Endocrinology. Elsevier. 2020;14:113–113.
Esquirol Caussa J, Herrero VE. Epidermal growth factor, innovation and safety. Med Clínica. 2015;145(7):305–12.
Surini S, Leonyza A, Suh CW. Formulation and in vitro penetration study of recombinant human epidermal growth factor-loaded transfersomal emulgel. Adv Pharm Bull. 2020;10(4):586–94.
Santana H, González Y, Campana PT, Noda J, Amarantes O, Itri R, et al. Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: Effect of pH, buffers, and excipients. Int J Pharm. 2013;452(1–2):52–62.
Taylor JM, Mitchell WM, Cohen S. Epidermal growth factor. J Biol Chem. 1972;247(18):5928–34.
Yang CH, Wu PC, Huang YB, Tsai YH. A new approach for determining the stability of recombinant human epidermal growth factor by thermal fourier transform infrared (ftir) microspectroscopy. J Biomol Struct Dyn. 2004;22(1):101–10.
Laurent GJ, Shapiro SD. Encyclopedia of Respiratory Medicine. Elsevier Science. 2006. https://books.google.co.id/books?id=OnZQAQAAIAAJ.
Chin D, Boyle GM, Parsons PG, Coman WB. What is transforming growth factor-beta (TGF-β)? Br J Plast Surg. 2004;57(3):215–21.
Attisano L, Ayyaz A, Wrana JL. Recent advances in understanding contextual TGFβ signaling. F1000Research. 2017;6(May):1–9.
Ong CH, Tham CL, Harith HH, Firdaus N, Israf DA. TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies. Eur J Pharmacol. 2021;911(September):174510.
Liang J, Zhou Y, Zhang N, Wang D, Cheng X, Li K, et al. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling. J Biol Chem. 2021;296:100512.
Yaniz-Galende E, Hajjar RJ. Stem cell and gene therapy for cardiac regeneration. Cardiac Regeneration and Repair, vol. 1. Woodhead Publishing Limited. 2014. https://doi.org/10.1533/9780857096708.4.347.
Duffy AM, Bouchier-Hayes DJ, Harmey JH. Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: Autocrine signalling by VEGF. VEGF Cancer. 2004;1:133–44.
Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF) – key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–67.
De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med. 2012;44(1):1–9.
Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, et al. Keratinocyte growth factor. Cell Biol Int. 1996;19(5):399–411.
Poorebrahim M, Sadeghi S, Ghorbani R, Asghari M, Abazari MF, Kalhor H, et al. In silico enhancement of the stability and activity of keratinocyte growth factor. J Theor Biol. 2017;418(January):111–21.
Borjian Boroujeni M, Shahbazi Dastjerdeh M, Shokrgozar MA, Rahimi H, Omidinia E. Computational driven molecular dynamics simulation of keratinocyte growth factor behavior at different pH conditions. Informatics Med Unlocked. 2021;23(October):100514.
Hsu E, Osslund T, Nybo R, Chen BL, Kenney WC, Morris CF, et al. Enhanced stability of recombinant keratinocyte growth factor by mutagenesis. Protein Eng Des Sel. 2006;19(4):147–53.
Sadeghi S, Kalhor H, Panahi M, Abolhasani H, Rahimi B, Kalhor R, et al. Keratinocyte growth factor in focus: A comprehensive review from structural and functional aspects to therapeutic applications of palifermin. Int J Biol Macromol. 2021;191(September):1175–90.
Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci U S A. 2001;98(15):8578–83.
Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, et al. Keratinocyte growth factor (KGF) regulates estrogen receptor-α (ER-α) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells. Anticancer Res. 2009;29(8):3195–205.
Ceccarelli S, Cardinali G, Aspite N, Picardo M, Marchese C, Torrisi MR, et al. Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes. Exp Cell Res. 2007;313(9):1758–77.
Braun S, Auf Dem Keller U, Steiling H, Werner S. Fibroblast growth factors in epithelial repair and cytoprotection. Philos Trans R Soc B Biol Sci. 2004;359(1445):753–7.
Lee JS, Liu JJ, Hong JW, Wilson SE. Differential expression analysis by gene array of cell cycle modulators in human corneal epithelial cells stimulated with epidermal growth factor (EGF), hepatocyte growth factor (HGF), or keratinocyte growth factor (KGF). Curr Eye Res. 2001;23(1):69–76.
Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers. N Engl J Med. 2004;351(25):2590–8.
Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes: Cellular Mechanisms of Wound Repair. Open Biol. 2020;10(9):200223.
Huang Y, Gou M, Zhang W, Xie H. Mesenchymal Stem Cells for Chronic Wound Healing : Current Status of Preclinical and Clinical Studies. Tissue Eng - Part B. 2020;26(6):555–70.
留言 (0)